Dr Reddy

Dr. Reddy's Laboratories has entered into a non-exclusive licensing agreement with American-based biopharmaceutical company, Gilead Scien...Read More

Hyderabad: Dr Reddy's Laboratories Ltd said the companys NDA (new drug application) Elyxyb ((celecoxib oral solution 25 mg/mL) has been a...Read More

New Delhi: Dr Reddy’s Laboratories announced that it has acquired 100 per cent stake in Imperial Credit Private Ltd, a Kolkata-based non-...Read More

New Delhi : FIPB will decide on 24 foreign investment proposals, including those of Vodafone India and Dr Reddy’s Laboratories, on Februa...Read More

Mumbai : Dr Reddy’s Laboratories Ltd has signed an agreement with Teva Pharmaceutical Industries Ltd and an affiliate of Allergan Plc to ...Read More

Hyderabad: The US Consumer Product Safety Commission has approached the US Department of Justice seeking action against Dr Reddy’s Labora...Read More

New Delhi: Drug major Dr Reddy’s Laboratories (DRL) has received US health regulator’s approval to market ZembraceSymTouch injection, a d...Read More

US FDA’s action may lead to no new active pharma ingredients approvals from the sites under regulatory lens, which may slow down the comp...Read More

Hyderabad:  Dr Reddy’s Laboratories, which is embroiled in a legal battle with AstraZeneca over the usage of purple colour for generic ve...Read More

AstraZeneca had moved the court objecting to use of purple colour by Dr Reddy’s in its generic of Nexium

MUMBAI : With Ranbaxy Laboratories Ltd’s troubles with the US regulator still fresh in the minds of investors, analysts expect sentiment ...Read More

Mumbai: The domestic stock market extended loses to a fifth straight session today as the benchmark BSE Sensex slipped by 181 points to f...Read More

New Delhi : Drug firm Dr Reddy’s Laboratories will acquire select portfolio of established brands of Belgian firm UCB in India, Nepal, Sr...Read More